CHICAGO, March 21, 2018 -- COSMOS HOLDINGS INC. (OTCQB:COSM) (“Company”) is pleased to announce that it has signed a definitive agreement with Marathon Global Inc. to source and procure medical cannabis products and their derivatives for clients of Cosmos in approved Countries in Cosmos’ distribution network of approximately 35,000 pharmacies across Europe.
“Marathon Global is superbly positioned within the global Cannabis industry and views the underserviced European market as a tremendous opportunity,” says Gavin Treanor, Marathon Global CEO. “We intend to provide a significant distribution channel to Canadian Licensed Producers while ensuring that only premium product is provided to Cosmos customers,” states Gavin Treanor.
“We are pleased to be Marathon’s exclusive partner and look forward to fulfilling the demand in the European medical cannabis space now and in the future, “states Grigorios Siokas, Cosmos CEO.
The completion of the transaction is subject to and conditional upon the terms of the definitive agreement being met.
ABOUT COSMOS HOLDINGS INC
COSMOS HOLDINGS INC. (OTCQB:COSM), is a fully reporting Pharmaceutical Holding Company based in Chicago, Illinois, USA, that specializes, through its subsidiaries, in the wholesale of pharmaceutical products throughout Europe. COSMOS is focused on identifying, acquiring, developing, and commercializing different medicines to improve patients’ lives. We have a large network of over 110 clients & vendors in Germany, United Kingdom, United Arab Emirates, Denmark, Italy, France, Singapore, Ireland, Sweden, Poland, Netherlands, and Greece. We have offices and distribution centers in Thessaloniki, Greece & In Harlow, UK. We have the ability to distribute our products to over 35,000 pharmacies throughout Europe.
ABOUT MARATHON GLOBAL INC
MARATHON GLOBAL INC. is a Canadian Private Company specializing in the offtake and supply of Cannabis and Cannabis Extracts globally from Licensed Producers (LP’s) and manufacturers to fulfill demand throughout Europe.
SAFE HARBOR STATEMENT
This Press Release may contain certain forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Cosmos Holdings, Inc. has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect Cosmos’ current beliefs and are based on information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause Cosmos' actual results, performance or achievements to differ materially from those expressed in or implied by such statements. Cosmos Holdings, Inc. undertakes no obligation to update or provide advice in the event of any change, addition or alteration to the information contained in this Press Release including such forward-looking statements.
Steve Carr
Managing Director
Dresner Corporate Services
(312) 780-7211
[email protected]
Integra Consulting Group LLC
Jeremy Roe
Managing Partner
+1 925 262 8305
[email protected]


Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Jetstar to Charge for Overhead Cabin Bags From February
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 



